Publications by authors named "Yoshiaki Sagara"

Claim this Profile
P
Postoperative course and safety profile of the suture scaffold technique in breast-conserving surgery: a single-institution observational study.
Reiko Mitsueda, Yasuyo Ohi, Yukari Mochitomi, Rie Takaki, Megumi Furukawa, Yoshiaki Sagara, Yasuaki Sagara

Breast Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer.
Reiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, Tetsuhiko Taira, Toshiko Miyaki, Yoshiaki Sagara

Breast Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Reiki Nishimura, Yoshitaka Fujiki, Tetsuhiko Taira, Toshiko Miyaki, Shuichi Kanemitsu, Yoshiaki Sagara, Yasuaki Sagara

Clin Breast Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Yoshitaka Fujiki, Masahiro Kashiwaba, Mutsumi Sato, Junko Kawano, Megumi Teraoka, Yoshiaki Sagara, Yasuaki Sagara

Breast Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Use of Texture Features and Morphological Classification Based on Dynamic Contrast-enhanced MR Imaging: Differentiating Benign and Malignant Breast Masses with High Negative Predictive Value.
Shigeharu Ohyu, Mitsuhiro Tozaki, Michiro Sasaki, Hisae Chiba, Qilin Xiao, Yoshiaki Sagara

Magn Reson Med Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Yoshiaki Sagara, Yasuaki Sagara

Ann Surg Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Yoshiaki Sagara, Yasuaki Sagara

Ann Surg Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.
Hirofumi Mukai, Yukari Uemura, Hiromitsu Akabane, Takanori Watanabe, Youngjin Park, Yoshiaki Sagara

Br J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis.
Kodai Nakamura, Naomi Hiyake, Tomofumi Hamada, Seiya Yokoyama, Kazuki Mori, Yasuaki Sagara, Yoshiaki Sagara

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Shozo Ohsumi, Hirofumi Mukai, Masato Takahashi, Yasuo Hozumi, Hiromitsu Akabane, Yoshiaki Sagara

Jpn J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer.
Toshihiro Tanaka, Maki Tanaka, Hidemi Furusawa, Yoshihiko Kamada, Yoshiaki Sagara

Anticancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence for breast cancer detection in mammography: experience of use of the ScreenPoint Medical Transpara system in 310 Japanese women.
Michiro Sasaki, Mitsuhiro Tozaki, Alejandro Rodríguez-Ruiz, Daisuke Yotsumoto, Yumi Ichiki, Yasuaki Sagara, Yoshiaki Sagara

Breast Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between F-FDG uptake on PET/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer.
Wakana Murakami, Mitsuhiro Tozaki, Michiro Sasaki, Akira I Hida, Yasuyo Ohi, Yoshiaki Sagara

Eur J Radiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Akira I Hida, Takahiro Watanabe, Yasuaki Sagara, Masahiro Kashiwaba, Yoshiaki Sagara

Breast Cancer Res Treat· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does integrated shimming improve lesion detection in whole-body diffusion-weighted examinations of patients with breast cancer?
Michiro Sasaki, Mitsuhiro Tozaki, Katsuya Maruyama, Thomas Benkert, Wakana Murakami, Yoshiaki Sagara

Jpn J Radiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.
Michiro Sasaki, Mitsuhiro Tozaki, Kazunori Kubota, Wakana Murakami, Daisuke Yotsumoto, Yasuaki Sagara, Yoshiaki Sagara

Jpn J Radiol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.
Takeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, Mitsuko Mouri, Yasuhiro Hagiwara, Yoshiaki Sagara

BMC Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Hiroji Iwata, Norikazu Masuda, Daigo Yamamoto, Yoshiaki Sagara, Nobuaki Sato

Breast Cancer Res Treat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
Akira I Hida, Yasuaki Sagara, Daisuke Yotsumoto, Shuichi Kanemitsu, Junko Kawano, Yoshiaki Sagara

Breast Cancer Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
Satoru Iwase, Takashi Kawaguchi, Daisuke Yotsumoto, Takako Doi, Kyuichiro Miyara, Yoshiaki Sagara

Support Care Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Tsutomu Takashima, Hirofumi Mukai, Fumikata Hara, Nobuaki Matsubara, Tsuyoshi Saito, Yoshiaki Sagara

Lancet Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer.
Yoshiaki Sagara, Kazuhiko Sato, Eisuke Fukuma, Kenji Higaki, Mitsuhiro Mizutani

Jpn J Clin Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
Yasuaki Sagara, Yasuyo Ohi, Ayami Matsukata, Daisuke Yotsumoto, Shinichi Baba, Yoshiaki Sagara, Yoshiatsu Sagara

Breast Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Yasuyo Ohi, Yoshihisa Umekita, Takako Yoshioka, Masakazu Souda, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara, Yoshiatsu Sagara

Histopathology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Shugo Tamada, Yasuaki Sagara, Shinichi Baba, Yoshiaki Sagara, Daisuke Yotsumoto, Yoshiatsu Sagara

Gan To Kagaku Ryoho· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis